Gladstone NOW: The Campaign Join Us on the Journey ✕
1 - 15 of 15 Results Clear All
The Scientist—Gladstone Investigator Isha Jain discovered that hypoxic conditions trigger red blood cells to absorb and utilize more glucose, reducing blood sugar and offering a potential therapy to control diabetes.
Gladstone Experts Diabetes Jain Lab
Reuters—Led by Gladstone Investigator Isha Jain, researchers found that low-oxygen conditions cause red blood cells to act like “glucose sponges,” lowering blood sugar.
Gladstone Experts Diabetes Jain Lab
New study shows red blood cells act as hidden glucose sponges in low-oxygen conditions, explaining why people living at high altitude have lower diabetes rates and pointing toward new treatments.
News Release Research (Publication) Diabetes Jain Lab
Genetic Engineering & Biotechnology News—In addition to genetic changes, environmental factors are associated with the development of birth defects. A new study led by Deepak Srivastava, president of Gladstone Institutes, reveals how maternal diabetes alters a small subset of cells in the developing heart in a way that can lead to congenital heart defects.
Gladstone Experts Congenital Heart Disease Diabetes Cardiovascular Disease Srivastava Lab Single Cell
The path to medical breakthroughs lies in bold, ambitious science
Donor Stories Institutional News Spinal Cord Injuries Alzheimer’s Disease Diabetes Roddenberry Stem Cell Center Bruneau Lab Ding Lab Huang Lab McDevitt Lab
Anti-cancer drug prevented less weight gain and caused mice to burn more calories thanks to higher levels of metabolism-boosting brown fat.
Ding Lab Metabolism Diabetes
Scientists at the Gladstone Institutes have discovered an unusual regulator of body weight and the metabolic syndrome: a molecular mechanism more commonly associated with brain cells.
Diabetes Neurological Disease Akassoglou Lab Basic Science Metabolism
Scientists at the Gladstone Institutes have successfully converted human skin cells into fully-functional pancreatic cells.
Diabetes Ding Lab Stem Cells/iPSCs
Finding could have implications for other autoimmune disorders, such as type I diabetes.
Multiple Sclerosis Diabetes
Advances made in the fields of virology and immunology often spread from one disease to another.
Ott Lab Diabetes Hepatitis C HIV/AIDS
With his unique combination of biology and chemistry, Gladstone’s Sheng Ding is quickly becoming a tour-de-force in the field of regenerative medicine.
Diabetes Ding Lab Stem Cells/iPSCs
A cure for type 1 diabetes has long eluded even the top experts. Not because they do not know what must be done—but because the tools did not exist to do it.
Diabetes Ding Lab Stem Cells/iPSCs
SAN FRANCISCO, CA—A cure for type 1 diabetes has long eluded even the top experts. Not because they do not know what must be done—but because the tools did not exist to do it.
Diabetes Cardiovascular Disease Ding Lab Stem Cells/iPSCs
SAN FRANCISCO, CA—Scientists at the Gladstone Institutes have discovered a key protein that regulates insulin resistance—the diminished ability of cells to respond to the action of insulin and which sets the stage for the development of the most common form of diabetes.
Akassoglou Lab Diabetes Metabolism
SAN FRANCISCO, CA—A scientist at the Gladstone Institutes has discovered how a gene known as SIRT3 contributes to a suite of health problems sweeping across America, offering new insight into how to combat these potentially fatal conditions.
Diabetes Metabolism
